GemPharmatech (688046.SH) shareholder Qingdao National Pharmaceutical reduced its holdings by 888,200 shares, decreasing its stake to 5%.

16:49 24/09/2024

Yaokang Biopharmaceuticals (688046.SH) announced that on September 24, 2024, the company's shareholder, Qingdao Guoyao Daichuang...

GemPharmatech (688046.SH) announced on September 24, 2024, that its shareholder Qingdao Guoyao DaChuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao Guoyao") has reduced its shareholding in the company by 888,200 shares through block trading, accounting for 0.22% of the total share capital of the company. After this equity change, Qingdao Guoyao holds a reduced stake of 5% in the company.

CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.